INFY NYSE Week ended 31 Jul 2026

Weekly Investor Report

Infosys Ltd ADR · Technology · Information Technology Services

Open interactive chart View report data
Latest close 12.03 USD
8.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -9.6% below the Trend Line and sits at 9.1% of its 52-week range. The latest completed week returned 8.3%, after a 7.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 43/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 82d.

Setup score 32 out of 100
Latest Close 12.03 USD 31 Jul 2026
1W Return 8.3% latest completed week
4W Return 7.8% short-term follow-through
12W Return -4.2% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 44.89% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 8.3% Latest completed week; four-week move 7.8%. Indicator stack 7/76 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Buy Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.89% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 43/100 conviction; expected move 9.4%. News sentiment 55/100 63 relevant articles in the latest sentiment read. Event risk 82d Next report is scheduled for 23 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -9.6% below the Trend Line and sits at 9.1% of its 52-week range. The latest completed week returned 8.3%, after a 7.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.8% over four weeks, -4.2% over 12 weeks, and -23.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W8.3%
4W7.8%
12W-4.2%
26W-30.1%
52W-23.9%
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.30Latest activity-pressure read.
Pressure change254.2%Four-week change in activity pressure.
Leadership-25.47Latest relative-leadership reading.
RS change23.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2026 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength78/100Blend of value, momentum, and quality. Underlying universe rank 23; rank 1 is best.
Value75/100Relative valuation strength. Underlying universe rank 26; rank 1 is best.
Quality93/100Profitability and accounting quality. Underlying universe rank 8; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth18/100Revenue and earnings growth. Underlying universe rank 83; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework92/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
13.5x
Price divided by trailing earnings.
Price / sales
2.2x
Market value relative to trailing revenue.
EV / EBITDA
8.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
30.3%
Gross profit retained from each unit of revenue.
Operating margin
22.0%
Operating profit retained from revenue.
Free-cash-flow margin
21.4%
Free cash flow generated from revenue.
Return on invested capital
41.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
4.1%
Latest one-year revenue growth.
EPS growth
3.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.7%
Cash dividends relative to market value.
Buyback yield
4.5%
Net share repurchases relative to market value.
Shareholder yield
9.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

INFY shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.13, expected move of 9.4%, and Sharemaestro trend signal inactive.

Conviction43/100
Expected move9.4%
Put/call volume0.13
Pressure79
Speculation6
Volatility84
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 63 relevant articles.

23 positive · 24 neutral · 16 negative
Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings82dNext report is scheduled for 23 Oct 2026; event risk rises as the date approaches.
Options expected move9.4%Nearest-chain priced movement where available.
52-week drawdown-59.0%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2617 weeks finished lower.
Best week+8.8%Week of 17 Apr.
Worst week-12.6%Week of 13 Feb.
Latest week+8.3%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains3
Flat weeks1
Modest losses11
Sharp losses6
Recent vol4.9%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split19/32Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis11/100

Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 44.89%

Next-week expectancy is negative with a 44.89% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors65/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 13 SVQF92/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 86.5 of 1013 Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal Options43/100

INFY shows bullish options pressure with a 43/100 conviction score, put-call volume ratio of 0.13, expected move of 9.4%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 9.4% Sentiment55/100

Weighted news tone is neutral across 63 relevant articles.

Infosys (NSEI:INFY) Stock Fair Value Falls After Analysts Cut Targets On Weaker Outlook Insiders50/100

No recent insider transaction evidence is stored.

 Earnings82d

Next report is scheduled for 23 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202612.03 USD8.3%13.30 USD16.99 USD0.30-25.47158.0MOff
24 Jul 202611.11 USD-3.3%13.49 USD17.01 USD-0.07-31.00137.0MOff
17 Jul 202611.49 USD5.0%13.74 USD17.03 USD-0.06-29.78128.7MOff
10 Jul 202610.94 USD-2.0%14.01 USD17.06 USD-0.17-34.90108.2MOff
3 Jul 202611.16 USD3.5%14.23 USD17.08 USD-0.19-33.4884.8MOff
26 Jun 202610.78 USD2.0%14.44 USD17.11 USD-0.11-35.16136.9MOff
19 Jun 202610.57 USD-10.0%14.66 USD17.13 USD-0.13-38.69128.9MOff
12 Jun 202611.74 USD-3.2%14.88 USD17.15 USD-0.13-32.1151.9MOff
5 Jun 202612.13 USD-2.0%15.03 USD17.17 USD-0.29-30.2698.0MOff
29 May 202612.38 USD-0.2%15.17 USD17.18 USD-0.52-31.3798.5MOff
22 May 202612.40 USD5.0%15.29 USD17.19 USD-0.80-31.02102.6MOff
15 May 202611.81 USD-5.9%15.44 USD17.21 USD-0.98-34.4265.0MOff
8 May 202612.55 USD2.8%15.57 USD17.22 USD-0.87-30.8862.9MOff
1 May 202612.21 USD-3.0%15.69 USD17.22 USD-0.91-31.8775.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.